Literature DB >> 14216513

THE ANTIPERSPIRANT ACTION OF TOPICALLY APPLIED ANTICHOLINERGICS.

F S MACMILLAN, H H RELLER, F H SYNDER.   

Abstract

Keywords:  ATROPINE; CARBAMATES; CLINICAL RESEARCH; EXPERIMENTAL LAB STUDY; PARASYMPATHOLYTICS; PHARMACOLOGY; RABBITS; SCOPOLAMINE; SWEATING; TOXICOLOGIC REPORT; UREA

Mesh：

Substances：

Year:  1964        PMID： 14216513     DOI： 10.1038/jid.1964.167

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN： 0022-202X            Impact factor:   8.551


× No keyword cloud information.
  9 in total

1.  Receptor binding studies of soft anticholinergic agents.

Authors:  F Huang; P Buchwald; C E Browne; H H Farag; W M Wu; F Ji; G Hochhaus; N Bodor
Journal:  AAPS PharmSci       Date:  2001

2.  Design, pharmacokinetic, and pharmacodynamic evaluation of a new class of soft anticholinergics.

Authors:  Fenglei Huang; Clinton E Browne; Whei-Mei Wu; Attila Juhász; Fubao Ji; Nicholas Bodor
Journal:  Pharm Res       Date:  2003-10       Impact factor: 4.200

Review 3.  Transdermal patches: history, development and pharmacology.

Authors:  Michael N Pastore; Yogeshvar N Kalia; Michael Horstmann; Michael S Roberts
Journal:  Br J Pharmacol       Date:  2015-03-18       Impact factor: 8.739

4.  Antiperspirant activity of H1-histamine blockers as determined by a modified rat foot pad assay.

Authors:  M D Helman; T A Re; A B Lukacsko
Journal:  Pharm Res       Date:  1989-10       Impact factor: 4.200

5.  Topical antiperspirants.

Authors:  H Francois; T W Johnson
Journal:  J Natl Med Assoc       Date:  1967-01       Impact factor: 1.798

6.  Axillary skin excision as a treatment for axillary hyperhidrosis.

Authors:  P C Weaver
Journal:  Postgrad Med J       Date:  1970-07       Impact factor: 2.401

7.  [On the pathogenesis of cholinergic urticaria. 3. The influence of sweat secretion inhibition on cholinergic urticaria].

Authors:  L Illig; A Heinicke
Journal:  Arch Klin Exp Dermatol       Date:  1967

8.  Pharmacokinetic and pharmacodynamic evaluations of the zwitterionic metabolite of a new series of N-substituted soft anticholinergics.

Authors:  Whei-Mei Wu; Peter Buchwald; Nobuhiro Mori; Fubao Ji; JiaXiang Wu; Nicholas Bodor
Journal:  Pharm Res       Date:  2005-09-26       Impact factor: 4.200

9.  Frey's syndrome.

Authors:  K Harrison; I Donaldson
Journal:  J R Soc Med       Date:  1979-07       Impact factor: 18.000
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.